New gel therapy aims to calm brain inflammation without harsh steroid side effects

This study tested whether H.P. Acthar Gel can improve symptoms and quality of life in people with CNS sarcoidosis, a rare condition where inflammation affects the brain and spinal cord. Four adults with the disease received the gel to see if it could control disease activity and reduce the need for strong steroids or immune-suppressing drugs. The goal was to find better, safer treatment options for this serious condition.